miR-21 affects lipogenesis, NAFLD, and cancer induction by its inhibitory effect on human polybromo-1 (HPB1) and PPAR-α [74, 75]. This evidence concerns the gene PBRM1 and metabolic dysfunction-associated steatotic liver disease.